 |
Beacon Therapeutics
Last updated: July 05, 2024
CEO - David Fellows
UK | Funding: $290.1M (+)
Website: https://www.beacontx.com
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
Website: https://www.beacontx.com
Beacon Therapeutics is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.
